Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal
Abstract The merozoite surface antigen Pf41 was previously identified among the top 10 of new malaria vaccine candidates. Pf41 possesses red blood cell binding regions and conserved domains. We used population genetics approaches to determine the genetic diversity and to identify regions under balan...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-00784-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850133341538353152 |
|---|---|
| author | Rokhaya Sané Babacar Souleymane Sambe Aissatou Diagne Joseph Faye Fatoumata Diene Sarr Serigne Ousmane Mbacké Diaw Ibrahima Sarr Arona Sabène Diatta Hélène Ataume Mawounge Diatta Papa Mbacké Sembène Inès Vigan-Womas Aissatou Toure-Balde Faith Osier Makhtar Niang |
| author_facet | Rokhaya Sané Babacar Souleymane Sambe Aissatou Diagne Joseph Faye Fatoumata Diene Sarr Serigne Ousmane Mbacké Diaw Ibrahima Sarr Arona Sabène Diatta Hélène Ataume Mawounge Diatta Papa Mbacké Sembène Inès Vigan-Womas Aissatou Toure-Balde Faith Osier Makhtar Niang |
| author_sort | Rokhaya Sané |
| collection | DOAJ |
| description | Abstract The merozoite surface antigen Pf41 was previously identified among the top 10 of new malaria vaccine candidates. Pf41 possesses red blood cell binding regions and conserved domains. We used population genetics approaches to determine the genetic diversity and to identify regions under balancing selection for the potential inclusion of Pf41 as candidate in a multicomponent vaccine. We screened 116 clinical isolates collected from different administrative regions in Senegal for P. falciparum positivity, Pf41 amplification and sequencing. We analyzed Pf41 sequences for polymorphism, natural selection, haplotype prevalence and linkage disequilibrium. Neutrality tests (Tajima’s D, FLD, FLF and MEME) were computed using DnaSP v6. and Datamonkey Hyphy. Population Analysis with Reticulate Trees (Popart) version 1.7 software was used to construct haplotypes network showing the distribution of haplotypes per study site. P. falciparum positivity from the 116 successfully tested samples was 93.1% of which 73 were successfully sequenced for Pf41. We found a low genetic diversity (π = 0.00144 ± 0.00022) and high haplotype diversity (Hd = 0.765 ± 0.037) of Pf41 sequences that can be attributed to linkage disequilibrium. We identified several substitutions under positive selection and negatively selected codons at inter-species level in the central and 6-Cys domains of Pf41, respectively. The predominant SNP S232R was found fixed by positive selection in Senegalese isolates. The genetic diversity of Pf41 antigen is low in clinical isolates from Senegal. With a central domain under balancing selection and two highly conserved 6-Cys domains under negative selection due to functional constraints, the Pf41 antigen appears as a good vaccine candidate. Further monitoring of allelic variants on larger and diverse sets of samples would justify the rational for functional assays and Pf41 integration in a multicomponent vaccine. |
| format | Article |
| id | doaj-art-5f69de0ae19d4e96b96375d6f3f35270 |
| institution | OA Journals |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-5f69de0ae19d4e96b96375d6f3f352702025-08-20T02:31:59ZengNature PortfolioScientific Reports2045-23222025-05-0115111010.1038/s41598-025-00784-yGenetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from SenegalRokhaya Sané0Babacar Souleymane Sambe1Aissatou Diagne2Joseph Faye3Fatoumata Diene Sarr4Serigne Ousmane Mbacké Diaw5Ibrahima Sarr6Arona Sabène Diatta7Hélène Ataume Mawounge Diatta8Papa Mbacké Sembène9Inès Vigan-Womas10Aissatou Toure-Balde11Faith Osier12Makhtar Niang13Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de DakarPôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de DakarPôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de DakarPôle Epidémiologie, Recherche Clinique et Sciences des Données, Institut Pasteur de DakarPôle Epidémiologie, Recherche Clinique et Sciences des Données, Institut Pasteur de DakarPôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de DakarPôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de DakarPôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de DakarPôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de DakarDépartement de Biologie Animale, Faculté des Sciences et Techniques, Université Cheikh Anta Diop de DakarPôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de DakarPôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de DakarCentre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research ProgrammePôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de DakarAbstract The merozoite surface antigen Pf41 was previously identified among the top 10 of new malaria vaccine candidates. Pf41 possesses red blood cell binding regions and conserved domains. We used population genetics approaches to determine the genetic diversity and to identify regions under balancing selection for the potential inclusion of Pf41 as candidate in a multicomponent vaccine. We screened 116 clinical isolates collected from different administrative regions in Senegal for P. falciparum positivity, Pf41 amplification and sequencing. We analyzed Pf41 sequences for polymorphism, natural selection, haplotype prevalence and linkage disequilibrium. Neutrality tests (Tajima’s D, FLD, FLF and MEME) were computed using DnaSP v6. and Datamonkey Hyphy. Population Analysis with Reticulate Trees (Popart) version 1.7 software was used to construct haplotypes network showing the distribution of haplotypes per study site. P. falciparum positivity from the 116 successfully tested samples was 93.1% of which 73 were successfully sequenced for Pf41. We found a low genetic diversity (π = 0.00144 ± 0.00022) and high haplotype diversity (Hd = 0.765 ± 0.037) of Pf41 sequences that can be attributed to linkage disequilibrium. We identified several substitutions under positive selection and negatively selected codons at inter-species level in the central and 6-Cys domains of Pf41, respectively. The predominant SNP S232R was found fixed by positive selection in Senegalese isolates. The genetic diversity of Pf41 antigen is low in clinical isolates from Senegal. With a central domain under balancing selection and two highly conserved 6-Cys domains under negative selection due to functional constraints, the Pf41 antigen appears as a good vaccine candidate. Further monitoring of allelic variants on larger and diverse sets of samples would justify the rational for functional assays and Pf41 integration in a multicomponent vaccine.https://doi.org/10.1038/s41598-025-00784-yPlasmodium falciparumPf416-CysGenetic diversityNatural selectionVaccine candidate |
| spellingShingle | Rokhaya Sané Babacar Souleymane Sambe Aissatou Diagne Joseph Faye Fatoumata Diene Sarr Serigne Ousmane Mbacké Diaw Ibrahima Sarr Arona Sabène Diatta Hélène Ataume Mawounge Diatta Papa Mbacké Sembène Inès Vigan-Womas Aissatou Toure-Balde Faith Osier Makhtar Niang Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal Scientific Reports Plasmodium falciparum Pf41 6-Cys Genetic diversity Natural selection Vaccine candidate |
| title | Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal |
| title_full | Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal |
| title_fullStr | Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal |
| title_full_unstemmed | Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal |
| title_short | Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal |
| title_sort | genetic diversity and natural selection of plasmodium falciparum pf41 vaccine candidate in clinical isolates from senegal |
| topic | Plasmodium falciparum Pf41 6-Cys Genetic diversity Natural selection Vaccine candidate |
| url | https://doi.org/10.1038/s41598-025-00784-y |
| work_keys_str_mv | AT rokhayasane geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT babacarsouleymanesambe geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT aissatoudiagne geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT josephfaye geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT fatoumatadienesarr geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT serigneousmanembackediaw geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT ibrahimasarr geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT aronasabenediatta geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT heleneataumemawoungediatta geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT papambackesembene geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT inesviganwomas geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT aissatoutourebalde geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT faithosier geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal AT makhtarniang geneticdiversityandnaturalselectionofplasmodiumfalciparumpf41vaccinecandidateinclinicalisolatesfromsenegal |